Det anbefaledes at medtage en advarsel i indlægssedlen om brugen under graviditet og den mulige risiko for seponeringssymptomer hos den nyfødte.
A warning concerning the use during pregnancy and the possible risk of withdrawal effects on the newborn were recommended to be included in the PIL.